Teva Pharmaceutical Industries Ltd. has begun commercially shipping Bupropion hydrochloride Extended-Release tablets, 150 mg, the generic version of Biovail Corporation's antidepressant Wellbutrin XL tablets, pursuant to its March 2007 agreement with Anchen Pharmaceuticals, Inc.

Wellbutrin XL tablets, 150 mg, marketed by GlaxoSmithKline, had US sales of approximately $930 million for the 12 months ended March 2008, according to IMS data.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products.